Fortuna A - Search Results

1

Unveiling the potential of intranasal delivery of renin-angiotensin system drugs: Insights on the pharmacokinetics of irbesartan.

Gouveia F, Carona A, Lacerda M, Bicker J, Camins A, Teresa Cruz M, Ettcheto M, Falcão A, Fortuna A. Gouveia F, et al. Among authors: fortuna a. Biochem Pharmacol. 2024 Dec;230(Pt 3):116616. doi: 10.1016/j.bcp.2024.116616. Epub 2024 Nov 9. Biochem Pharmacol. 2024. PMID: 39528072 Free article.

2

Intranasal delivery of paroxetine: A preclinical study on pharmacokinetics, depressive-like behaviour, and neurochemical sex differences.

Silva S, Bicker J, Fialho S, Cunha S, Falcão A, Fortuna A. Silva S, et al. Among authors: fortuna a. Biochem Pharmacol. 2024 May;223:116184. doi: 10.1016/j.bcp.2024.116184. Epub 2024 Mar 30. Biochem Pharmacol. 2024. PMID: 38556027 Free article.

3

Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future.

Gouveia F, Camins A, Ettcheto M, Bicker J, Falcão A, Cruz MT, Fortuna A. Gouveia F, et al. Among authors: fortuna a. Ageing Res Rev. 2022 May;77:101612. doi: 10.1016/j.arr.2022.101612. Epub 2022 Mar 26. Ageing Res Rev. 2022. PMID: 35346852 Free article. Review.

4

Intranasal drug delivery: how, why and what for?

Pires A, Fortuna A, Alves G, Falcão A. Pires A, et al. Among authors: fortuna a. J Pharm Pharm Sci. 2009;12(3):288-311. doi: 10.18433/j3nc79. J Pharm Pharm Sci. 2009. PMID: 20067706 Free article. Review.

5

Relevance of Breast Cancer Resistance Protein to Brain Distribution and Central Acting Drugs: A Pharmacokinetic Perspective.

Goncalves J, Bicker J, Alves G, Fortuna A, Falcao A. Goncalves J, et al. Among authors: fortuna a. Curr Drug Metab. 2018;19(12):1021-1041. doi: 10.2174/1389200219666180629121033. Curr Drug Metab. 2018. PMID: 29956624 Review.

6

Nose-to-brain delivery of levetiracetam after intranasal administration to mice.

Gonçalves J, Bicker J, Gouveia F, Liberal J, Oliveira RC, Alves G, Falcão A, Fortuna A. Gonçalves J, et al. Among authors: fortuna a. Int J Pharm. 2019 Jun 10;564:329-339. doi: 10.1016/j.ijpharm.2019.04.047. Epub 2019 Apr 20. Int J Pharm. 2019. PMID: 31015006

7

Nose-to-brain Delivery of Natural Compounds for the Treatment of Central Nervous System Disorders.

Bicker J, Fortuna A, Alves G, Falcão A. Bicker J, et al. Among authors: fortuna a. Curr Pharm Des. 2020;26(5):594-619. doi: 10.2174/1381612826666200115101544. Curr Pharm Des. 2020. PMID: 31939728 Review.

8

Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics.

Bicker J, Alves G, Falcão A, Fortuna A. Bicker J, et al. Among authors: fortuna a. Br J Pharmacol. 2020 May;177(10):2215-2239. doi: 10.1111/bph.15017. Epub 2020 Mar 20. Br J Pharmacol. 2020. PMID: 32056195 Free PMC article. Review.

9

Pre-Clinical Assessment of the Nose-to-Brain Delivery of Zonisamide After Intranasal Administration.

Gonçalves J, Alves G, Carona A, Bicker J, Vitorino C, Falcão A, Fortuna A. Gonçalves J, et al. Among authors: fortuna a. Pharm Res. 2020 Mar 25;37(4):74. doi: 10.1007/s11095-020-02786-z. Pharm Res. 2020. PMID: 32215749

10

QbD-driven development of intranasal lipid nanoparticles for depression treatment.

Vitorino C, Silva S, Gouveia F, Bicker J, Falcão A, Fortuna A. Vitorino C, et al. Among authors: fortuna a. Eur J Pharm Biopharm. 2020 Aug;153:106-120. doi: 10.1016/j.ejpb.2020.04.011. Epub 2020 Jun 7. Eur J Pharm Biopharm. 2020. PMID: 32525033

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

535 results

Search Page

Filters